Plain-English translation of NCT07605611 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
After surgery to remove low rectal cancer, doctors often create a temporary surgical pouch (called a diverting stoma) to protect the surgical connection inside your body while it heals. This trial is testing whether โ a medication that reduces fluid in your digestive system โ combined with a clear liquid diet for 7 days after surgery can work just as well as creating that pouch, while avoiding the complications and quality-of-life effects that come with having one.
While a temporary surgical pouch is effective at preventing serious complications after low rectal cancer surgery, it requires a second operation to close it later, can cause infection and skin problems, and affects daily life and comfort. This trial wants to find out if the medication and diet approach might offer patients the same safety without those extra burdens.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have surgery to remove your rectal cancer. Afterward, you'll be randomly assigned to one of two groups: one group will receive medication plus a clear liquid diet for 7 days without having a surgical pouch created, and the other group will have a temporary surgical pouch placed as standard care. You'll be monitored closely in the hospital and during follow-up visits to check for complications and how well you're healing. The study team will track your recovery, bowel function, and quality of life for up to 3 years after your surgery.
AI-generated summary from trial data ยท Aug 14, 2026 ยท Not medical advice
China